These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 18161713)
41. Treatment of hepatitis C in HIV-coinfected patients at the CROI. Barreiro P AIDS Rev; 2004; 6(1):63. PubMed ID: 15168743 [No Abstract] [Full Text] [Related]
42. Rethinking hepatitis C viral kinetics: Insights into host-virus interactions in 'difficult-to-treat' groups and implications for novel treatment approaches. Yeung E; Chung RT J Hepatol; 2005 Nov; 43(5):748-50. PubMed ID: 16171895 [No Abstract] [Full Text] [Related]
43. Prescribing practices for the treatment of hepatitis C in a Veterans Affairs medical center. Mangin EF; Jones WN Am J Health Syst Pharm; 2004 Jul; 61(14):1479-82. PubMed ID: 15332696 [No Abstract] [Full Text] [Related]
45. Predictors of response of US veterans to treatment for the hepatitis C virus. Backus LI; Boothroyd DB; Phillips BR; Mole LA Hepatology; 2007 Jul; 46(1):37-47. PubMed ID: 17567830 [TBL] [Abstract][Full Text] [Related]
46. Co-infections. German doctors treat hepatitis C early, with some success. TreatmentUpdate; 2006; 18(5):3-4. PubMed ID: 17209229 [No Abstract] [Full Text] [Related]
48. [Treatment of acute hepatitis C with PEG-interferon and ribavirin]. Nicolas I; Pons JA Gastroenterol Hepatol; 2003 Apr; 26(4):275-6. PubMed ID: 12681125 [No Abstract] [Full Text] [Related]
49. Hepatitis C virus infection: a current review. Senecal DL; Morelli J JAAPA; 2007 Oct; 20(10):21-5. PubMed ID: 18019325 [No Abstract] [Full Text] [Related]
50. Quality of life with pegylated interferon therapy for hepatitis C. Brown RS Hepatology; 2002 Sep; 36(3):767-8; author reply 768. PubMed ID: 12198677 [No Abstract] [Full Text] [Related]
51. Pegylated interferon for the treatment of hepatitis C virus in haemodialysis patients. Teta D; Lüscher BL; Gonvers JJ; Francioli P; Phan O; Burnier M Nephrol Dial Transplant; 2005 May; 20(5):991-3. PubMed ID: 15741205 [No Abstract] [Full Text] [Related]
52. Interferon/pegylated interferon and ribavirin in HCV-associated kidney disease with or without cryoglobulinemia. Bruchfeld A; Lindahl K; Stahle L; Schvarcz R J Hepatol; 2006 Feb; 44(2):432-3; author reply 433. PubMed ID: 16338023 [No Abstract] [Full Text] [Related]
53. Is there discrimination in access to therapy for HCV patients? Garattini S J Hepatol; 2008 Oct; 49(4):491-3. PubMed ID: 18678432 [No Abstract] [Full Text] [Related]
54. [Drug therapy of hepatitis B and C]. Färkkilä M Duodecim; 2003; 119(6):519-29. PubMed ID: 12708339 [No Abstract] [Full Text] [Related]
55. Peginterferon and ribavirin for hepatitis C. Abramowicz M N Engl J Med; 2007 Mar; 356(12):1270-1; author reply 1271. PubMed ID: 17378100 [No Abstract] [Full Text] [Related]
56. Treatment of recurrent hepatitis C. Gane E Liver Transpl; 2002 Oct; 8(10 Suppl 1):S28-37. PubMed ID: 12362295 [TBL] [Abstract][Full Text] [Related]
58. Infection with hepatitis C virus genotype 4 is associated with a poor response to interferon-alpha. Sherman M; Marinos G; Sedarati F Ann Intern Med; 2001 Nov; 135(10):927-8. PubMed ID: 11712887 [No Abstract] [Full Text] [Related]
59. Recent advances in hepatitis C virus research and understanding the biology of the virus. Lunel-Fabiani F World J Gastroenterol; 2007 May; 13(17):2404-5. PubMed ID: 17552022 [No Abstract] [Full Text] [Related]